Skip to main content

ORIGINAL RESEARCH article

Front. Endocrinol.
Sec. Diabetes: Molecular Mechanisms
Volume 15 - 2024 | doi: 10.3389/fendo.2024.1401780
This article is part of the Research Topic Dietary and Nutrigenetic Contributors to Metabolic Syndrome View all 8 articles

Weight Loss-Independent Changes in Human Growth Hormone During Water-Only Fasting: A Secondary Evaluation of a Randomized Controlled Trial

Provisionally accepted
Benjamin D. Horne Benjamin D. Horne 1,2*Jeffrey L. Anderson Jeffrey L. Anderson 1,3Heidi T. May Heidi T. May 1Tami L. Bair Tami L. Bair 1Viet Le Viet Le 1,4Leslie Iverson Leslie Iverson 1Kirk U. Knowlton Kirk U. Knowlton 1,3Joseph B. Muhlestein Joseph B. Muhlestein 1,3
  • 1 Intermountain Healthcare, Salt Lake City, Utah, United States
  • 2 Stanford University, Stanford, California, United States
  • 3 The University of Utah, Salt Lake City, Utah, United States
  • 4 Rocky Mountain University of Health Professions, Provo, Utah, United States

The final, formatted version of the article will be published soon.

    Introduction: Water-only fasting for one day or more may provide health benefits independent of weight loss. Human growth hormone (HGH) may play a key role in multiple fasting-triggered mechanisms. Whether HGH changes during fasting are independent of weight loss and how basal HGH and HGH change relate to other fasting-induced changes are unknown. Methods: Apparently healthy individuals (N=30) were randomized by Latin square to begin two days with either 24-hour water-only fasting or a control of 24-hour ad libitum eating. On day 2, subjects were crossed over to control (if day 1 was fasting) or fasting (if they ate on day 1). HGH, weight, and other parameters were measured at baseline and at the end of the first and second days. Results: Baseline HGH had median 0.50 ng/mL for females (n=20) and 0.04 ng/mL for males (n=10), and correlated inversely with weight, glucose, insulin, and triglycerides and positively with changes in insulin and HOMA-IR. The 24-hour fasting-induced HGH change was uncorrelated with weight loss (r= 0.01, p=0.98), but correlated with changes in glucose, HGB, and IGF-1. The percent increase in HGH was greater (p<0.001) for lower (females ≤0.15 ng/mL, males ≤0.05 ng/mL) vs. higher baseline HGH (median: 1,225% vs. 50.3%, respectively). Subjects with lower baseline HGH had a trend to greater reduction of HOMA-IR (median: -6.15 vs. -1.35 for lower vs. higher HGH, respectively, p=0.08). Conclusions: Fasting increased HGH and the HGH changes were independent of weight loss. Basal HGH and fasting-induced HGH changes correlated inversely with cardiometabolic risk factors.

    Keywords: 23 ; Tables: 2. 2 Trial registration: clinicaltrials.gov, NCT01059760 (FEELGOOD Trial, January 28, 2010) intermittent fasting, Prolonged fasting, Extended fasting, periodic fasting

    Received: 15 Mar 2024; Accepted: 23 Dec 2024.

    Copyright: © 2024 Horne, Anderson, May, Bair, Le, Iverson, Knowlton and Muhlestein. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Benjamin D. Horne, Intermountain Healthcare, Salt Lake City, 84107, Utah, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.